Evaluating impurities in drugs Part I

Evaluating impurities in drugs Part I

Impurity control in starting materials used to manufacture APIs has long been expected by regulatory agencies. An API starting material is a raw material, intermediate, or API that is used in the production of an API and that is incorporated as a significant structural element into the API. API star...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical technology Europe 2012-02, Vol.24 (2), p.15
Hauptverfasser: Wadekar, Kashyap R, Bhalme, Mitali, Rao, S Srinivasa, Reddy, K Vigneshwar, Kumar, L Sampath, Balasubrahmanyam, E
Format: Artikel
Sprache:eng
Schlagworte:
Analgesics
By products
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 15
container_title Pharmaceutical technology Europe
container_volume 24
creator Wadekar, Kashyap R
Bhalme, Mitali
Rao, S Srinivasa
Reddy, K Vigneshwar
Kumar, L Sampath
Balasubrahmanyam, E
description Impurity control in starting materials used to manufacture APIs has long been expected by regulatory agencies. An API starting material is a raw material, intermediate, or API that is used in the production of an API and that is incorporated as a significant structural element into the API. API starting materials normally have defined chemical properties and structure.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1151851633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2815437101</sourcerecordid><originalsourceid>FETCH-proquest_journals_11518516333</originalsourceid><addsrcrecordid>eNpjYeA0NDc11jW3NDPnYOAqLs4yMAAKmBpzMqi6liXmlCaWZOalK2TmFpQWZZZkphYrZOYppBSVphcrBCQWlSh48jCwpiXmFKfyQmluBmU31xBnD92CovzC0tTikvis_NKiPKBUvKGhqaGFqaGZsbExcaoApywuPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1151851633</pqid></control><display><type>article</type><title>Evaluating impurities in drugs Part I</title><source>EBSCOhost Business Source Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Wadekar, Kashyap R ; Bhalme, Mitali ; Rao, S Srinivasa ; Reddy, K Vigneshwar ; Kumar, L Sampath ; Balasubrahmanyam, E</creator><creatorcontrib>Wadekar, Kashyap R ; Bhalme, Mitali ; Rao, S Srinivasa ; Reddy, K Vigneshwar ; Kumar, L Sampath ; Balasubrahmanyam, E</creatorcontrib><description>Impurity control in starting materials used to manufacture APIs has long been expected by regulatory agencies. An API starting material is a raw material, intermediate, or API that is used in the production of an API and that is incorporated as a significant structural element into the API. API starting materials normally have defined chemical properties and structure.</description><identifier>ISSN: 1753-7967</identifier><language>eng</language><publisher>Monmouth Junction: MultiMedia Healthcare Inc</publisher><subject>Analgesics ; By products</subject><ispartof>Pharmaceutical technology Europe, 2012-02, Vol.24 (2), p.15</ispartof><rights>Copyright Advanstar Communications, Inc. Feb 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Wadekar, Kashyap R</creatorcontrib><creatorcontrib>Bhalme, Mitali</creatorcontrib><creatorcontrib>Rao, S Srinivasa</creatorcontrib><creatorcontrib>Reddy, K Vigneshwar</creatorcontrib><creatorcontrib>Kumar, L Sampath</creatorcontrib><creatorcontrib>Balasubrahmanyam, E</creatorcontrib><title>Evaluating impurities in drugs Part I</title><title>Pharmaceutical technology Europe</title><description>Impurity control in starting materials used to manufacture APIs has long been expected by regulatory agencies. An API starting material is a raw material, intermediate, or API that is used in the production of an API and that is incorporated as a significant structural element into the API. API starting materials normally have defined chemical properties and structure.</description><subject>Analgesics</subject><subject>By products</subject><issn>1753-7967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpjYeA0NDc11jW3NDPnYOAqLs4yMAAKmBpzMqi6liXmlCaWZOalK2TmFpQWZZZkphYrZOYppBSVphcrBCQWlSh48jCwpiXmFKfyQmluBmU31xBnD92CovzC0tTikvis_NKiPKBUvKGhqaGFqaGZsbExcaoApywuPw</recordid><startdate>20120201</startdate><enddate>20120201</enddate><creator>Wadekar, Kashyap R</creator><creator>Bhalme, Mitali</creator><creator>Rao, S Srinivasa</creator><creator>Reddy, K Vigneshwar</creator><creator>Kumar, L Sampath</creator><creator>Balasubrahmanyam, E</creator><general>MultiMedia Healthcare Inc</general><scope>3V.</scope><scope>7RV</scope><scope>7WY</scope><scope>7XB</scope><scope>883</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>KB0</scope><scope>L.-</scope><scope>M0F</scope><scope>NAPCQ</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20120201</creationdate><title>Evaluating impurities in drugs Part I</title><author>Wadekar, Kashyap R ; Bhalme, Mitali ; Rao, S Srinivasa ; Reddy, K Vigneshwar ; Kumar, L Sampath ; Balasubrahmanyam, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_11518516333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Analgesics</topic><topic>By products</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wadekar, Kashyap R</creatorcontrib><creatorcontrib>Bhalme, Mitali</creatorcontrib><creatorcontrib>Rao, S Srinivasa</creatorcontrib><creatorcontrib>Reddy, K Vigneshwar</creatorcontrib><creatorcontrib>Kumar, L Sampath</creatorcontrib><creatorcontrib>Balasubrahmanyam, E</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ABI/INFORM Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Trade &amp; Industry (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Trade &amp; Industry</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Pharmaceutical technology Europe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wadekar, Kashyap R</au><au>Bhalme, Mitali</au><au>Rao, S Srinivasa</au><au>Reddy, K Vigneshwar</au><au>Kumar, L Sampath</au><au>Balasubrahmanyam, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluating impurities in drugs Part I</atitle><jtitle>Pharmaceutical technology Europe</jtitle><date>2012-02-01</date><risdate>2012</risdate><volume>24</volume><issue>2</issue><spage>15</spage><pages>15-</pages><issn>1753-7967</issn><abstract>Impurity control in starting materials used to manufacture APIs has long been expected by regulatory agencies. An API starting material is a raw material, intermediate, or API that is used in the production of an API and that is incorporated as a significant structural element into the API. API starting materials normally have defined chemical properties and structure.</abstract><cop>Monmouth Junction</cop><pub>MultiMedia Healthcare Inc</pub></addata></record>
fulltext fulltext
identifier ISSN: 1753-7967
ispartof Pharmaceutical technology Europe, 2012-02, Vol.24 (2), p.15
issn 1753-7967
language eng
recordid cdi_proquest_journals_1151851633
source EBSCOhost Business Source Complete; EZB-FREE-00999 freely available EZB journals
subjects Analgesics
By products
title Evaluating impurities in drugs Part I
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A38%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluating%20impurities%20in%20drugs%20Part%20I&rft.jtitle=Pharmaceutical%20technology%20Europe&rft.au=Wadekar,%20Kashyap%20R&rft.date=2012-02-01&rft.volume=24&rft.issue=2&rft.spage=15&rft.pages=15-&rft.issn=1753-7967&rft_id=info:doi/&rft_dat=%3Cproquest%3E2815437101%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1151851633&rft_id=info:pmid/&rfr_iscdi=true